InvestorsHub Logo
Followers 1322
Posts 247472
Boards Moderated 55
Alias Born 12/07/2009

Re: None

Friday, 11/17/2017 2:32:04 PM

Friday, November 17, 2017 2:32:04 PM

Post# of 2804248
Regen BioPharma, Inc. (RGBP) 0.088+0.014 (+18.92%) Regen BioPharma Inc. Chairman Discusses the Rationale for Pursuing Autoimmune Indications by Activating the Nuclear Receptor NR2F6 https://finance.yahoo.com/news/regen-biopharma-inc-chairman-discusses-210100342.html?soc_src=social-sh&soc_trk=tw via @YahooFinance @frontpagestocks #TeamFPS


ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.